PatrickAndrewBrownMD
Pediatric Hematology & Oncology • Baltimore, MDPediatric Hematologic Oncology
Associate Professor of Oncology, Assistant Professor of Pediatrics, Johns Hopkins University School of Medicine; Director, Pediatric Leukemia and Lymphoma Program
Dr. Brown is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
The Johns Hopkins Hospital (Main Entrance)
1800 Orleans St. The Charlotte R. Bloomberg Children's Center Building, 11th Floor
Baltimore, MD 21287Phone+1 410-955-8751- Is this information wrong?
Education & Training
Johns Hopkins UniversityFellowship, Pediatric Hematology/Oncology, 2001 - 2004- Johns Hopkins UniversityResidency, Pediatrics, 1998 - 2001
Medical University of South CarolinaClass of 1998
Certifications & Licensure
MD State Medical License 2001 - 2022
Clinical Trials
- Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia Start of enrollment: 2010 Aug 09
- Risk-Adapted Chemotherapy in Treating Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia or Localized B-Lineage Lymphoblastic Lymphoma Start of enrollment: 2010 Aug 09
- Clinical Study of Vorinostat in Combination With Etoposide in Pediatric Patients < 21 Years at Diagnosis With Refractory Solid Tumors Start of enrollment: 2011 Feb 09
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsHLH-like toxicities predict poor survival after the use of tisagenlecleucel in children and young adults with B-ALL.Kevin O McNerney, Stephanie J Si Lim, Kyle Ishikawa, Alexandra Dreyzin, Anant Vatsayan, John J Chen, Christina Baggott, Snehit Prabhu, Holly L Pacenta, Christine Phili...> ;Blood Advances. 2023 Jun 27
- 5 citationsNSD2 E1099K drives relapse in pediatric acute lymphoblastic leukemia by disrupting 3D chromatin organization.Sonali Narang, Nikki A Evensen, Jason Saliba, Joanna Pierro, Mignon L Loh, Patrick A Brown, Pandurang Kolekar, Heather Mulder, Ying Shao, John Easton, Xiaotu Ma, Arist...> ;Genome Biology. 2023 Apr 4
- 10 citationsThree-year results from phase I of ZUMA-4: KTE-X19 in pediatric relapsed/refractory acute lymphoblastic leukemia.Alan S Wayne, Van Huynh, Nobuko Hijiya, Rayne H Rouce, Patrick A Brown, Joerg Krueger, Carrie L Kitko, Edward Dela Ziga, Michelle L Hermiston, Michael K Richards, Andr...> ;Haematologica. 2023 Mar 1
- Join now to see all
Abstracts/Posters
- Sorafenib in Combination with Standard Chemotherapy for Children with High Allelic Ratio FLT3/ITD+ AML Improves Event-Free Survival and Reduces Relapse Risk: A Report ...Patrick A. Brown, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Single Cell Sequencing Reveals Heterogeneity of Gene Expression in KMT2A Rearranged Infant ALL at Relapse Compared to DiagnosisPatrick A. Brown, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- A Phase 2 Trial of Inotuzumab Ozogamicin (InO) in Children and Young Adults with Relapsed or Refractory (R/R) CD22+ B-Acute Lymphoblastic Leukemia (B-ALL): Results fro...Patrick A. Brown, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Press Mentions
- Johns Hopkins University: Young Johns Hopkins Children’s Center Patient Shows Superhero Powers in Fight with CancerSeptember 7th, 2021
Hospital Affiliations
Johns Hopkins Childrens CenterBaltimore, Maryland
External Links
- Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/patrick-brown
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
